论文部分内容阅读
目的:观察重组脑利钠肽(rhBNP)应用于急性心梗介入术后的疗效。方法:将84例急性心梗介入术后的患者随机进行分组,应用常规方案治疗组(对照组),应用常规方案加rhBNP治疗组(研究组)。观察记录应用药物前后的生命体征、心功能分级、血清脑利钠肽、心梗指标和液体出入量。结果:两组的心电图、血浆BNP、心肌酶谱、出入量均有明显差异。两组不良反应比较,差异有统计学意义(P<0.05)。结论:重组脑利钠肽应用于急性心梗介入术后的疗效优于硝酸甘油(对照组里面没有写硝酸甘油)。
Objective: To observe the effect of recombinant brain natriuretic peptide (rhBNP) in the treatment of acute myocardial infarction. Methods: Eighty-four patients with acute myocardial infarction were randomly divided into two groups. The patients in the control group received conventional regimen and the rhBNP-treated group (study group). Observed and recorded the application of drugs before and after the vital signs, cardiac function classification, serum brain natriuretic peptide, myocardial infarction index and fluid access. Results: Electrocardiogram, plasma BNP, myocardial zymogram, the amount of both have significant differences. Adverse reactions between the two groups, the difference was statistically significant (P <0.05). Conclusion: The effect of recombinant brain natriuretic peptide in the treatment of acute myocardial infarction is better than that of nitroglycerin (nitroglycerin is not written in the control group).